Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03513120 · ClinicalTrials.gov registry record
Return to Sport After Posterior Spinal Fusion
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 30
- Enrollment target
NCT03513120: Completed study, sponsored by University of Colorado, Denver.
NCT03513120 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03513120 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The primary purpose of this prospective study is to determine when adolescent athletes with idiopathic scoliosis are able to return to sports participation after posterior spinal fusion surgery.
Primary Outcome
Identify at what time patients return to sports without any restrictions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2020-08-31 |
What the finished NCT03513120 record still lists
NCT03513120 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03513120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03513120 about?
NCT03513120 is a clinical study titled "Return to Sport After Posterior Spinal Fusion". The primary purpose of this prospective study is to determine when adolescent athletes with idiopathic scoliosis are able to return to sports participation after posterior spinal fusion surgery.
What is the current status of trial NCT03513120?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-03-08. Estimated completion is 2020-08-31.
Who is sponsoring clinical trial NCT03513120?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI